Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: old-fashioned (3), old (260), square (21)

Docetaxel

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) DOCETAXEL (75) Regimen NSCLC – Docetaxel (75) Indication Second line therapy of stage IIIB
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxelver12.pdf

Cisplatin and Pemetrexed

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-PEMETREXED Regimen NSCLC – Cisplatin-Pemetrexed Indication First line therapy of stage III
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandPemetrexedver12.pdf

MesoCisPemVer1.3

Description: Chemotherapy Protocol MESOTHELIOMA CISPLATIN-PEMETREXED Regimen Mesothelioma – Cisplatin-Pemetrexed Indication First line therapy of advanced pleural mesothelioma where the disease is
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/MesoCisPemVer1.3.pdf

Data protection and confidentiality policy

Description: University Hospitals Southampton NHS Foundation Trust needs to collect and use information about people with whom it deals in order to
Url: /Media/UHS-website-2019/Docs/Policies/Data-protection-and-confidentiality-policy.pdf

Enhertu (trastuzumab deruxtecan)

Description: Chemotherapy Protocol BREAST CANCER ENHERTU (trastuzumab deruxtecan) ENHERTU is NOT the same drug as Kadcyla (trastuzumab emtansine) or generic trastuzumab). There
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Enhertu-trastuzumab-deruxtecan.pdf

TCC-ICA-PCAF-Round 1-Chairs-Report

Description: HEE/NIHR Pre-doctoral Clinical Academic Fellowship Scheme Round 1 (2018) Chairs’ Report ICA PCAF R1: Chairs’ Report Introduction The ICA
Url: /Media/Southampton-Clinical-Research/Downloads/TCC-ICA-PCAF-Round-1-Chairs-Report.pdf

PIS COVID-19 immsup adults V2.1

Description: Participant Information Study Title: Coronavirus infection in immunosuppressed children and adults. Chief Investigator: H. de Graaf Principal investigators: H. de Graaf
Url: /Media/Southampton-Clinical-Research/COVID-19/ImmunoCOVID/PIS-COVID-19-immsup-adults-V2.1.pdf

ImmunoCOVID19 info for parents or carers and children aged 16-17

Description: Participant Information for parents/carers and children aged 16-17 years Study Title: Coronavirus infection in primary or secondary immunosuppressed children
Url: /Media/Southampton-Clinical-Research/Downloads/Immunocovid/ImmunoCOVID19-info-for-parents-or-carers-and-children-aged-16-17.pdf

PIS COVID-19 immsup child - over 16 yrs and parents V1.6

Description: Participant Information for parents/carers and children aged 16-17 years Study Title: Coronavirus infection in primary or secondary immunosuppressed children
Url: /Media/Southampton-Clinical-Research/COVID-19/PIS-COVID-19-immsup-child-over-16-yrs-and-parents-V1.6.pdf

Your breast prosthesis fitting appointment - patient information

Description: This factsheet explains what a breast prosthesis is, what a breast prosthesis fitting appointment is and what will happen at your
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Your-breast-prosthesis-fitting-appointment-4069-PIL.pdf

321 to 330 of 1000

Previous … 31 32 33 34 35 … Next